June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Susceptibility of Stenotrophomonasmaltophilia to Antibiotics and Contact Lens Multipurpose Solutions
Author Affiliations & Notes
  • Keizo Watanabe
    Ophthalmology, Kinki University Faculty of Medicine, Osakasayama, Japan
    Brien Holden Vision Institute, Sydney, NSW, Australia
  • Hua Zhu
    Brien Holden Vision Institute, Sydney, NSW, Australia
  • Rani Bandara
    Brien Holden Vision Institute, Sydney, NSW, Australia
  • Shiro Higaki
    Ophthalmology, Kinki University Faculty of Medicine, Osakasayama, Japan
  • Masahiko Fukuda
    Ophthalmology, Kinki University Faculty of Medicine, Osakasayama, Japan
  • Yoshikazu Shimomura
    Ophthalmology, Kinki University Faculty of Medicine, Osakasayama, Japan
  • Mark Willcox
    Brien Holden Vision Institute, Sydney, NSW, Australia
  • Brien Holden
    Ophthalmology, Kinki University Faculty of Medicine, Osakasayama, Japan
  • Footnotes
    Commercial Relationships Keizo Watanabe, None; Hua Zhu, Brien Holden Vision Institute (E); Rani Bandara, None; Shiro Higaki, None; Masahiko Fukuda, None; Yoshikazu Shimomura, None; Mark Willcox, Allergan Inc (C), Allergan Inc (R), Brien Holden Vision Institute (P), Bausch + Lomb (C), Basuch + Lomb (R); Brien Holden, Allergan (F), AMO (I)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 4285. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Keizo Watanabe, Hua Zhu, Rani Bandara, Shiro Higaki, Masahiko Fukuda, Yoshikazu Shimomura, Mark Willcox, Brien Holden; Susceptibility of Stenotrophomonasmaltophilia to Antibiotics and Contact Lens Multipurpose Solutions. Invest. Ophthalmol. Vis. Sci. 2013;54(15):4285.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To determine the susceptibility of Australian ocular isolates of S. maltophilia to antibiotics, and to various contact-lens-multipurpose solutions (MPS).

Methods: A total of 40 strains of S. maltophilia isolated from either contact lenses or lens storage cases of contact lens wearers were tested in the study. Bacterial susceptibilities to antibiotics were determined using a disc diffusion test. The antibiotics tested included trimethoprim-sulfamethozole, tigecycline, fluoroquinolones, aminoglycosides, β-lactams, chloramphenicol, and polymyxin B. Susceptibility of test strains to seven commonly used MPS was determined by using a broth microdilution method.

Results: The resistant rates of isolates were 93% to imipenem, 15% to aztreonam, 13% to chloramphenicol, and 8% to cefepime. None of the isolates was resistant to trimethoprim-sulfamethozole, tigecycline, ceftazidime, gatifloxacin, levofloxacin, or moxifloxacin. The susceptibility of test strains to the test MPS varied with MIC levels ranging from 3% to 100% (full strength) MPS. The test strains were less susceptible to the MPSs containing single disinfectant (PHMB) and the MPS containing PQ-1 and Aldox than to the three recently available MPS containing dual disinfectants (p < 0.05).

Conclusions: The Australian ocular isolates of S. maltophilia remain susceptible to trimethoprim-sulfamethozole, tigecycline, and most fluoroquinolones, but are less susceptible to MPS containing single or certain dual disinfectant/s.

Keywords: 422 antibiotics/antifungals/antiparasitics • 477 contact lens  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×